Market Research Logo

Global Botulinum Toxin & HA Dermal Filler Market: Industry Analysis & Outlook (2018-2022)

Global Botulinum Toxin & HA Dermal Filler Market: Industry Analysis & Outlook (2018-2022)

Botulinum Toxin (Botox or BTX) is a poisonous natural protein, created by the bacteria named Clostridium Botulinum. Generally, botulinum toxin is used by the surgeons to obstruct the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction. According to the exotoxins, botulinum toxin can be classified into eight product types including botulinum toxin A, B, C1, D, E, F, G and H.

Hyaluronic Acid (HA) is a naturally occurring non-sulfated glycosaminoglycan polymer component of the extracellular matrix that consists of repeat disaccharide units of glucuronic acid and N-acetyl-glucosamine. HA dermal fillers are widely used to replace and restore human tissue and are commonly used in medical aesthetic surgeries. However, unlike botulinum toxin which is directly used to restrict a particular muscle movement, HA dermal fillers are directly injected into the skin to fill wrinkles /dermal or folded points on the body part.

The U.S. emerged as a major region for the botulinum toxin and HA dermal fillers market, due to increased demand for minimally invasive or non-invasive facial cosmetic procedures by the residents of the U.S. supported by growth in their respective disposable income and increased tertiary health care concerns with the development of ageing symptoms.

The global botulinum toxin and HA dermal filler market is expected to grow with emerging middle class population, rising female populace in the workforce, increasing pharmaceutical R&D spending, growing health care expenditure and accelerating economic growth. Key trends of this market includes increasing plastic surgeon population, rising demand for minimally invasive procedures in the U.S. and growing preference for combination therapy.
However, there are some factors which can hinder growth of the market including stringent regulations, patient health-associated risks, dominance of botulinum toxin and HA Dermal Filler alternatives and limited access to patent rights.

The report “Global Botulinum Toxin and HA Dermal Filler Market: Industry Analysis & Outlook (2018-2022)” by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers, key tends & developments and challenges of the market, covering the U.S., Europe, Japan, Korea, China along with the global market. The report profiles the key players of the market including Allergan Plc, Ipsen S.A., Shanghai Haohai Biological Technology Co. Ltd and Medytox Inc.


1. Market Overview
1.1 Aesthetics
Table 1: Medical Aesthetics Procedure Categories
Table 2: Medical Aesthetic Procedure Product Types
1.2 Botulinum Toxin
Table 3: Botulinum Toxin-A Major Product Description
Table 4: Application of Botulinum Toxin
1.3 HA Dermal Filler
2. Global Aesthetic Market
2.1 Medical Aesthetic Procedures
Table 5: Global Medical Aesthetic Procedures (2013-2017)
2.2 Medical Aesthetic Procedures Forecast
Table 6: Global Medical Aesthetic Procedures Forecast (2018-2022)
2.3 Medical Aesthetic Procedures by Category
Table 7: Global Medical Aesthetic Procedures by Category (2017)
2.4 Medical Aesthetic Procedures by Product Types
Table 8: Global Medical Aesthetic Procedures by Product Types (2017)
3. Global Botulinum Toxin and HA Dermal Filler Market
3.1 Botulinum Toxin Market
3.1.1 Global Botulinum Toxin Market by Value
Table 9: Global Botulinum Toxin Market by Value (2013-2017)
3.1.2 Global Botulinum Toxin Market Forecast by Value
Table 10: Global Botulinum Toxin Market Forecast by Value (2018-2022)
3.1.3 Global Botulinum Toxin Market Value by Region
Table 11: Global Botulinum Toxin Market Value by Region (2017)
3.1.4 Global Botulinum Toxin Market Value by Application
Table 12: Global Botulinum Toxin Market Value by Application (2017)
3.1.5 Global Botulinum Toxin Therapeutics Market by Value
Table 13: Global Botulinum Toxin Therapeutics Market by Value (2013-2017)
3.1.6 Global Botulinum Toxin Therapeutics Market Forecast by Value
Table 14: Global Botulinum Toxin Therapeutics Market Forecast by Value (2018-2022)
3.1.7 Global Botulinum Toxin Medical Aesthetics Market by Value
Table 15: Global Botulinum Toxin Medical Aesthetics Market by Value (2013-2017)
3.1.8 Global Botulinum Toxin Medical Aesthetics Market Forecast by Value
Table 16: Global Botulinum Toxin Medical Aesthetics Market Forecast by Value (2018-2022)
3.1.9 Global Botulinum Toxin Medical Aesthetics Procedures
Table 17: Global Botulinum Toxin Medical Aesthetics Procedures (2013-2017)
3.1.10 Global Botulinum Toxin Medical Aesthetics Procedures Forecast
Table 18: Global Botulinum Toxin Medical Aesthetics Procedures Forecast (2018-2022)
3.1.11 Global Botulinum Toxin Medical Aesthetics Procedures by Region
Table 19: Global Botulinum Toxin Medical Aesthetics Procedures by Region (2017)
3.2 HA Dermal Filler Market
3.2.1 Global HA Dermal Filler Market by Value
Table 20: Global HA Dermal Filler Market by Value (2013-2017)
3.2.2 Global HA Dermal Filler Market Forecast by Value
Table 21: Global HA Dermal Filler Market Forecast by Value (2018-2022)
3.2.3 Global HA Dermal Filler Procedures
Table 22 Global HA Dermal Filler Procedures (2013-2017)
3.2.4 Global HA Dermal Filler Procedures Forecast
Table 23: Global HA Dermal Filler Procedures Forecast (2018-2022)
3.2.5 Global HA Dermal Filler Procedures by Region
Table 24: Global HA Dermal Filler Procedures by Region (2017)
4. Regional Botulinum Toxin and HA Dermal Filler Market
4.1 The U.S.
4.1.1 The U.S. Botulinum Toxin Market by Value
Table 25: The U.S. Botulinum Toxin Market by Value (2013-2017)
4.1.2 The U.S. Botulinum Toxin Market Forecast by Value
Table 26: The U.S. Botulinum Toxin Market Forecast by Value (2018-2022)
4.1.3 The U.S. Botulinum Toxin Market Value by Application
Table 27: The U.S. Botulinum Toxin Market Value by Application (2017)
4.1.4 The U.S. Botulinum Toxin Therapeutics Market by Value
Table 28: The U.S. Botulinum Toxin Therapeutics Market by Value (2013-2017)
4.1.5 The U.S. Botulinum Toxin Therapeutics Market Forecast by Value
Table 29: The U.S. Botulinum Toxin Therapeutics Market Forecast by Value (2018-2022)
4.1.6 The U.S. Botulinum Toxin Medical Aesthetics Market by Value
Table 30: The U.S. Botulinum Toxin Medical Aesthetics Market by Value (2013-2017)
4.1.7 The U.S. Botulinum Toxin Medical Aesthetics Market Forecast by Value
Table 31: The U.S. Botulinum Toxin Medical Aesthetics Market Forecast by Value (2018-2022)
4.1.8 The U.S. Botulinum Toxin Medical Aesthetics Procedures Forecast
Table 32: The U.S. Botulinum Toxin Medical Aesthetics Procedures Forecast (2017-2022)
4.1.9 The U.S. HA Dermal Filler Procedures Forecast
Table 33: The U.S. HA Dermal Filler Procedures Forecast (2017-2022)
4.2 Europe
4.2.1 Europe Botulinum Toxin Market by Value
Table 34: Europe Botulinum Toxin Market by Value (2013-2017)
4.2.2 Europe Botulinum Toxin Market Forecast by Value
Table 35: Europe Botulinum Toxin Market Forecast by Value (2018-2022)
4.2.3 Europe Botulinum Toxin Market Value by Application
Table 36: Europe Botulinum Toxin Market Value by Application (2017)
4.2.4 Europe Botulinum Toxin Therapeutics Market by Value
Table 37: Europe Botulinum Toxin Therapeutics Market by Value (2013-2017)
4.2.5 Europe Botulinum Toxin Therapeutics Market Forecast by Value
Table 38: Europe Botulinum Toxin Therapeutics Market Forecast by Value (2018-2022)
4.2.6 Europe Botulinum Toxin Medical Aesthetics Market by Value
Table 39: Europe Botulinum Toxin Medical Aesthetics Market by Value (2013-2017)
4.2.7 Europe Botulinum Toxin Medical Aesthetic Market Forecast by Value
Table 40: Europe Botulinum Toxin Medical Aesthetic Market Forecast by Value (2018-2022)
4.3 Japan
4.3.1 Japan Botulinum Toxin Market by Value
Table 41: Japan Botulinum Toxin Market by Value (2013-2017)
4.3.2 Japan Botulinum Toxin Market Forecast by Value
Table 42: Japan Botulinum Toxin Market Forecast by Value (2018-2022)
4.4 Korea
4.4.1 Korea Botulinum Toxin Market by Value
Table 43: Korea Botulinum Toxin Market by Value (2013-2017)
4.4.2 Korea Botulinum Toxin Market Forecast by Value
Table 44: Korea Botulinum Toxin Market Forecast by Value (2018-2022)
4.4.3 Korea Botulinum Toxin Medical Aesthetic Procedures Forecast
Table 45: Korea Botulinum Toxin Medical Aesthetic Procedures Forecast (2017-2022)
4.4.4 Korea HA Dermal Filler Market by Value
Table 46: Korea HA Dermal Filler Market by Value (2013-2017)
4.4.5 Korea HA Dermal Filler Market Forecast by Value
Table 47: Korea HA Dermal Filler Market Forecast by Value (2018-2022)
4.5 China
4.5.1 China HA Dermal Filler Market by Value
Table 48: China HA Dermal Filler Market by Value (2013-2017)
4.5.2 China HA Dermal Filler Market Forecast by Value
Table 49: China HA Dermal Filler Market Forecast by Value (2018-2022)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Emerging Middle Class Population
Table 50: Global Middle Class Population (2015-2028)
5.1.2 Rising Females in the Workforce
Table 51: Global Working Women Population (2013-2017)
5.1.3 Increasing Pharmaceutical R&D Spending
Table 52: Global Pharmaceutical R&D Spending (2013-2017)
5.1.4 Growing Health Care Expenditure
Table 53: Global Health Care Expenditure (2013-2017)
5.1.5 Accelerating Economic Growth
Table 54: Global GDP Per Capita (2013-2017)
5.2 Key Trends and Developments
5.2.1 Increasing Plastic Surgeon Population
Table 55: Global Plastic Surgeon Population (2013-2017)
5.2.2 Rising Demand for Minimally Invasive Procedures in the U.S.
Table 56: The U.S. Aesthetic Procedures (2013-2017)
5.2.3 Growing Preference for Combination Therapy
5.3 Challenges
5.3.1 Stringent Regulations
5.3.2 Patient Health-Associated Risk
5.3.3 Dominance of Botulinum Toxin and HA Dermal Filler Alternatives
5.3.4 Limited Access to Patent Rights
6. Competitive Landscape
6.1 Global Market
6.1.1 Revenue Comparison of Key Players
Table 57: Key Players – Revenues Comparison (2017)
6.1.2 Global Botulinum Toxin Major Brands by Company
Table 58: Global Botulinum Toxin Major Brands by Company (2017)
6.1.3 Botulinum Toxin Market Share by Company
Table 59: Global Botulinum Toxin Market Share by Company (2017)
6.1.4 Global HA Dermal Filler Market Share by Company
Table 60: Global HA Dermal Filler Market Share by Company (2017)
6.2 Regional Market
6.2.1 Korea Botulinum Toxin Market Share by Company
Table 61: Korea Botulinum Toxin Market Share by Company (2017)
6.2.2 Korea HA Dermal Filler Market Share by Company
Table 62: Korea HA Dermal Filler Market Share by Company (2017)
6.2.3 China Botulinum Toxin Market Share by Company
Table 63: China Botulinum Toxin Market Share by Company (2017)
6.2.4 China HA Dermal Filler Market Share by Company
Table 64: China HA Dermal Filler Market Share by Company (2017)
7. Company Profiles
7.1 Allergan Plc
7.1.1 Business Overview
Table 65: Allergan Plc Net Revenues by Business Segments (2017)
7.1.2 Financial Overview
Table 66: Allergan Plc Net Revenues and Net Income (Loss) (2013-2017)
7.1.3 Business Strategies
Table 67: Allergan Plc Research and Development Expenditures (2015-2017)
7.2 Ipsen S.A.
7.2.1 Business Overview
Table 68: Ipsen S.A. Net Sales by Business Segments (2017)
7.2.2 Financial Overview
Table 69: Ipsen S.A. Net Sales and Net Profit (2013-2017)
7.2.3 Business Strategies
Table 70: Ipsen S.A. Research and Development Expenditures (2015-2017)
Table 71: Ipsen S.A. Significant Agreements (2017/2018)
7.3 Shanghai Haohai Biological Technology Co. Ltd
7.3.1 Business Overview
Table 72: Shanghai Haohai Biological Technology Revenues by Business Segments (2017)
7.3.2 Financial Overview
Table 73: Shanghai Haohai Biological Technology Revenues and Net Profit (2014-2017)
7.3.3 Business Strategies
Table 74: Shanghai Haohai Biological Technology R&D Expenditures (2015-2017)
7.4 Medytox Inc.
7.4.1 Business Overview
Table 75: Medytox Inc. Product Pipeline (2018)
7.4.2 Financial Overview
Table 76: Medytox Inc. Revenues and Net Profit (2014-2017)
7.4.3 Business Strategies

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report